arrow
J

João Sérgio Neves

Universidade do Porto
H指数:31
被引数:3,623

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative analysis of machine learning and regularized regression models for predicting cardiovascular outcomes in patients with type 2 diabetes after acute coronary syndrome

比较机器学习和正则化回归模型在预测2型糖尿病急性冠脉综合征患者心血管结局中的应用分析

2026-07-220
OAAI
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis

在2型糖尿病和慢性肾病中,根据基线治疗目标使用非奈利酮的结局:一项FIDELITY分析

2026-04-240
OAAI
GLP-1 Receptor Agonists for the Prevention of New-Onset Heart Failure: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials

GLP-1受体激动剂预防新发心力衰竭:一项针对安慰剂对照随机临床试验的系统评价和荟萃分析

2025-11-250
OAAI
Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials

SGLT2抑制剂在心血管-肾脏-代谢疾病中不同白蛋白尿水平下的效果:一项随机试验的合并分析

2025-11-100
OAAI
Sodium–glucose co-transporter 2 inhibitors in severe estimated glomerular filtration rate deterioration across cardiovascular-kidney- metabolic conditions: A pooled analysis of randomized trials

钠-葡萄糖共转运蛋白2抑制剂在心血管-肾脏-代谢疾病中严重估计肾小球滤过率恶化的应用:一项随机试验的合并分析

2025-11-090
OAAI
Overweight and obesity in adults with type 1 diabetes: associations with glycemic control and cardiometabolic risk

成人1型糖尿病患者的超重和肥胖:与血糖控制及 cardiometabolic 风险的关联

2025-10-182
PRE
Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices

胰高血糖素样肽1受体激动剂在射血分数降低的心力衰竭合并植入式心脏设备患者中的起始应用效果

2025-09-230
PRE
Lifestyle Measures and the Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study

生活方式干预措施与代谢功能障碍相关脂肪性肝病的风险:一项横断面研究

2025-09-010
OA
Association of thyroid function within the normal range with glycemic control and cardiovascular risk factors in type 1 diabetes

甲状腺功能在正常范围内与1型糖尿病患者的血糖控制和心血管风险因素的相关性

2025-07-150
PRE